These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2330900)

  • 1. Decreased coronary vasodilatory capacity in hypertrophic cardiomyopathy determined by split-dose thallium-dipyridamole myocardial scintigraphy.
    Koga Y; Yamaguchi R; Ogata M; Kihara K; Toshima H
    Am J Cardiol; 1990 May; 65(16):1134-9. PubMed ID: 2330900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
    Astarita C; Nicolai E; Liguori E; Gambardella S; Rumolo S; Maresca FS
    G Ital Cardiol; 1998 Sep; 28(9):996-1004. PubMed ID: 9788038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of oral dipyridamole on myocardial perfusion and cardiac performance in patients with hypertrophic cardiomyopathy.
    Koga Y; Kihara K; Yamaguchi R; Wada T; Toshima H
    Am Heart J; 1992 Feb; 123(2):433-8. PubMed ID: 1736582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decreased coronary reserve in patients with hypertrophic cardiomyopathy--a study using split dose thallium-201 dipyridamole myocardial imaging].
    Yamaguchi R
    Kokyu To Junkan; 1987 Jan; 35(1):97-103. PubMed ID: 3563138
    [No Abstract]   [Full Text] [Related]  

  • 5. Dipyridamole-induced ST segment depression during thallium-201 imaging in patients with coronary artery disease: angiographic and hemodynamic determinants.
    Chambers CE; Brown KA
    J Am Coll Cardiol; 1988 Jul; 12(1):37-41. PubMed ID: 3379218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertrophic non-obstructive cardiomyopathy assessed by dipyridamole thallium single photon emission computed tomography: comparisons with hypertrophic cardiomyopathy with a dilated heart].
    Mori T; Suda K; Ohnishi M; Kanoh Y; Shiotani H; Yokota Y; Fujitani K; Fukuzaki H; Maeda K
    J Cardiol; 1987 Mar; 17(1):35-46. PubMed ID: 3501444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dipyridamole thallium-201 myocardial scintigraphy in coronary diagnosis; a comparison of methods with thallium-201 myocardial scintigraphy after ergometer stress].
    Neuzner J; Kornecki P; Kremer P; Grebe S; Schlepper M
    Z Kardiol; 1987 Dec; 76(12):737-43. PubMed ID: 3439248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy.
    Cannon RO; Dilsizian V; O'Gara PT; Udelson JE; Schenke WH; Quyyumi A; Fananapazir L; Bonow RO
    Circulation; 1991 May; 83(5):1660-7. PubMed ID: 2022023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of myocardial scintigraphy with 201Tl for differential diagnosis of ischemic heart disease and hypertrophic cardiomyopathy in women].
    Spizhovyĭ VN; Kramer AA; Gasilin VS; Liakishev AA; Samoĭlenko LE
    Kardiologiia; 1983 Aug; 23(8):51-5. PubMed ID: 6684709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of coronary stenosis by myocardial scintigraphy with thallium-201 after dipyridamol infusion].
    Pirelli S; Inglese E; Suppa M; Corrada E; Piccalò G; Campolo L; Carù B
    G Ital Cardiol; 1985 May; 15(5):520-5. PubMed ID: 4054490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative comparison of thallium-201 scintigraphy after exercise and dipyridamole in coronary artery disease.
    Varma SK; Watson DD; Beller GA
    Am J Cardiol; 1989 Oct; 64(14):871-7. PubMed ID: 2801554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography.
    Camici P; Chiriatti G; Lorenzoni R; Bellina RC; Gistri R; Italiani G; Parodi O; Salvadori PA; Nista N; Papi L
    J Am Coll Cardiol; 1991 Mar; 17(4):879-86. PubMed ID: 1999624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy.
    von Dohlen TW; Prisant LM; Frank MJ
    Am J Cardiol; 1989 Sep; 64(8):498-503. PubMed ID: 2773793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
    Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
    Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired coronary vasodilatory capacity after dipyridamole administration in hypertrophic cardiomyopathy.
    Shimamatsu M; Toshima H
    Jpn Heart J; 1987 May; 28(3):387-401. PubMed ID: 3626022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome.
    Yamada M; Elliott PM; Kaski JC; Prasad K; Gane JN; Lowe CM; Doi Y; McKenna WJ
    Eur Heart J; 1998 Mar; 19(3):500-7. PubMed ID: 9568455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thallium-dipyridamole in acute myocardial infarction treated by thrombolysis: diagnostic and prognostic value].
    D'Urbano M; Cafiero F; Cammelli F; Spreafico GL; Romano S
    G Ital Cardiol; 1994 Jan; 24(1):11-20. PubMed ID: 8200491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial thallium defects in apical hypertrophic cardiomyopathy are associated with a benign prognosis. Thallium defects in apical hypertrophy.
    Lee KH; Jang HJ; Lee SC; Kim YH; Lee EJ; Seo JD; Kim BT
    Int J Cardiovasc Imaging; 2003 Oct; 19(5):381-8. PubMed ID: 14609187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of in-hospital cardiac events using dipyridamole-thallium scintigraphy performed very early after acute myocardial infarction.
    Bosch X; Magriñá J; March R; Sanz G; García A; Betriu A; Navarro-López F
    Clin Cardiol; 1996 Mar; 19(3):189-96. PubMed ID: 8674255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radionuclide imaging after coronary vasodilation: myocardial scintigraphy with thallium-201 and radionuclide angiography after administration of dipyridamole.
    Sochor H; Pachinger O; Ogris E; Probst P; Kaindl F
    Eur Heart J; 1984 Jun; 5(6):500-9. PubMed ID: 6745292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.